Genematrix

At a glance

Genematrix filed 20 disclosures in the last 12 months, including 7 insider. The most recent key filing was on Jul 23.

Revenue for 2025 was ₩10.6B, up 6.2% on 2024. It made an operating loss of ₩679.1M. Debt was 56% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩5.4B and operating profit of ₩66.2M.

The 2025 annual report lists 69 employees with an average tenure of 4.2 years and average pay of ₩47.3M, #1577 of 1,829 listed companies by average pay. Its 4 directors and auditors were paid ₩273M each on average. It paid no cash dividend for 2025. 김수옥 and related parties held 15.95% at year end.

From the 2025 annual report

Staff: 69 (33 men, 36 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩3.1B. Directors and auditors: 4, paid ₩1.1B in total.

No cash dividend was paid for 2025.

Largest shareholder

김수옥 holds 8.67%; with 3 related parties the group holds 15.95% of common shares at year end.

Auditor: 한울회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary